BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37517000)

  • 1. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
    Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
    Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
    Mann S; Jess T; Allin K; Elmahdi R
    Clin Transl Gastroenterol; 2022 Jul; 13(7):e00513. PubMed ID: 35905421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Chen Y; Chen L; Xing C; Deng G; Zeng F; Xie T; Gu L; Yang H
    BMC Gastroenterol; 2020 Jun; 20(1):192. PubMed ID: 32552882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Shen Z; Zhang M; Liu Y; Ge C; Lu Y; Shen H; Zhu L
    BMJ Open; 2024 Mar; 14(3):e074659. PubMed ID: 38453206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
    Zhang XY; Dong HC; Wang WF; Zhang Y
    World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
    Chen Y; Wang X
    Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the prevalence of uveitis between Crohn's disease and ulcerative colitis: A systematic review and meta-analysis.
    Lin H; Zhang J; Liang C; Wu D; Tan Y; Luo L; Liu Z
    Acta Ophthalmol; 2024 Jun; 102(4):e485-e492. PubMed ID: 37830172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.
    Limketkai BN; Iheozor-Ejiofor Z; Gjuladin-Hellon T; Parian A; Matarese LE; Bracewell K; MacDonald JK; Gordon M; Mullin GE
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012839. PubMed ID: 30736095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
    Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
    Kuenzig ME; Bishay K; Leigh R; Kaplan GG; Benchimol EI;
    Clin Transl Gastroenterol; 2018 Sep; 9(9):188. PubMed ID: 30250122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Zhan Y; Cheng X; Mei P; Wu J; Ou Y; Cui Y
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1075-1087. PubMed ID: 37577790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
    Khalaji A; Babajani N; Amirsardari Z; Saeedian B; Peiman S; Berger NA; Behnoush AH
    Inflamm Bowel Dis; 2024 Apr; 30(4):629-640. PubMed ID: 37669127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
    Jayasooriya N; Baillie S; Blackwell J; Bottle A; Petersen I; Creese H; Saxena S; Pollok RC;
    Aliment Pharmacol Ther; 2023 Mar; 57(6):635-652. PubMed ID: 36627691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
    Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.
    Moninuola OO; Milligan W; Lochhead P; Khalili H
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1428-1439. PubMed ID: 29620794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.